Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 23 Jan 2024 for Mirati Therapeutics, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Bruce l. A. Carter: trading record in brief
Bruce l. A. Carter has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Mirati Therapeutics, Inc. and Enanta Pharmaceuticals Inc. We count 6 filings; the first trade dates from 14 January 2022 and the latest from 23 January 2024.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 23 January 2024, reports a transaction in Mirati Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Bruce l. A. Carter
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
6,021 sharesCommon StockSEC:0001140361-24-003535:0
6,808 shares@ US$58.7558.0% of flowCommon StockSEC:0001628280-24-000292:0
4,444 shares0Common StockSEC:0001214659-23-001041:0
10,000 shares@ US$27.0042.0% of flowCommon StockSEC:0001214659-22-010296:0
6,000 shares@ US$25.58100.0% of flowCommon StockSEC:0001062993-22-008344:0
2,546 shares0Common StockSEC:0001214659-22-000848:0
6 of 6 declarations
